← Back to Search

Wearable Robotic Orthosis

MyoMo for Spinal Cord Injury (MyoMo in SCI Trial)

N/A
Waitlist Available
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 10 weeks
Awards & highlights

MyoMo in SCI Trial Summary

This trial looks at whether the MyoPro device can help improve upper extremity function in people with incomplete spinal cord injury.

Eligible Conditions
  • Spinal Cord Injury

MyoMo in SCI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Brain signals measurement
CUE-Q
GRASSP
+3 more

MyoMo in SCI Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: MyoProExperimental Treatment1 Intervention
Receiving MyoMo training in-clinic and at home for 6-weeks
Group II: ControlActive Control1 Intervention
Receiving conventional therapy/training in-clinic and using their prescribed static brace (or others) at home for 6-weeks
Group III: Myo-SBActive Control1 Intervention
Receiving MyoMo training in-clinic and using their prescribed static brace (or others) at home for 6-weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MyoMo
2019
N/A
~20

Find a Location

Who is running the clinical trial?

United States Department of DefenseFED
866 Previous Clinical Trials
327,292 Total Patients Enrolled
Kessler FoundationLead Sponsor
174 Previous Clinical Trials
10,723 Total Patients Enrolled

Media Library

Spinal Cord Injury Research Study Groups: MyoPro, Control, Myo-SB
Spinal Cord Injury Clinical Trial 2023: MyoPro Highlights & Side Effects. Trial Name: NCT04855812 — N/A
MyoPro (Wearable Robotic Orthosis) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04855812 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still capacity for participants to join this exploration?

"Verifying the data hosted on clinicaltrials.gov, this medical trial is still searching for volunteers to take part in the research. Originally posted on October 27th 2019 and most recently updated on May 23rd 2022, 24 participants need to be found from a single site."

Answered by AI

What is the maximum capacity of this experiment's participants?

"Affirmative. According to the information posted on clinicaltrials.gov, this trial is currently enrolling subjects; it had its inception on October 27th 2019 and was most recently updated on May 23rd 2022. 24 participants are expected from 1 facility."

Answered by AI

Is it feasible for me to join this clinical experiment?

"This medical trial is enrolling two dozen individuals suffering from spinal cord injuries who are between 18 and 80 years of age. For consideration, applicants must be able to maintain functional tasks for an hour with rests as needed, demonstrate muscular activation in their biceps/triceps and forearm muscles, have been diagnosed with SCI at least a year ago, remain medically stable, comply with instructions given by study staff (who will speak English), refrain from altering current medication dosages, display visible muscle contraction on the upper extremity along with full passive range of motion through elbow flexion & extension."

Answered by AI

Is eligibility for this research restricted to those over 20 years of age?

"The study is open to participants of legal age (18 and over) up until the age of 80."

Answered by AI

Who else is applying?

What state do they live in?
Illinois
New York
How old are they?
< 18
What site did they apply to?
Kessler Foundation
What portion of applicants met pre-screening criteria?
Met criteria
~3 spots leftby May 2025